A carregar...
Two decades with omalizumab: what we still have to learn
From its availability for clinical use nearly two decades ago for severe asthma, omalizumab has gained strong evidence of efficacy and safety in the treatment of severe asthma not controlled by standard-of-care therapy. It has been acknowledged by Global Initiative on Asthma guidelines as add-on the...
Na minha lista:
| Publicado no: | Biologics |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6208531/ https://ncbi.nlm.nih.gov/pubmed/30464389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S180846 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|